A NIS Evaluating Injectable Treatments in Patients With Relapsing Multiple Sclerosis

Condition:   Relapsing Multiple Sclerosis
Interventions:   Other: ofatumumab;   Other: glatiramer acetate;   Other: interferon β1
Sponsor:   Novartis Pharmaceuticals
Recruiting